Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Clinical Genetics, |
RCV001837550 | SCV002009194 | pathogenic | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001837550 | SCV002098244 | pathogenic | not provided | 2022-02-21 | criteria provided, single submitter | clinical testing | Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at a significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 23221806, 25525159, 19085937) |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV002291301 | SCV002583757 | pathogenic | Trichothiodystrophy 1, photosensitive | 2022-07-20 | criteria provided, single submitter | clinical testing | PVS1, PM2, PS3 |
Labcorp Genetics |
RCV001837550 | SCV003443398 | pathogenic | not provided | 2024-06-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln662*) in the ERCC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ERCC2 are known to be pathogenic (PMID: 9238033, 11335038, 19085937, 19934020). This variant is present in population databases (rs778479250, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with trichothiodystrophy (PMID: 19085937). ClinVar contains an entry for this variant (Variation ID: 1319436). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003470890 | SCV004194651 | pathogenic | Cerebrooculofacioskeletal syndrome 2 | 2023-08-14 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001837550 | SCV005092796 | pathogenic | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | ERCC2: PVS1, PM2, PM3:Supporting |